Catherine J Mader

Title: The Innovative Contributions of Catherine J Mader

Introduction

Catherine J Mader is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of multidrug-resistant inhibitors. Her work is essential in addressing the challenges posed by drug resistance in various diseases.

Latest Patents

Catherine holds a patent for the "Synthesis of acridine derivative multidrug-resistant inhibitors." This patent details the synthesis of the MDRI of formula (I) from intermediates of acridone acid of formula (II) and aminophenethyl isoquinoline of formula (III). The process involves several steps, including coupling and conversion, to yield the MDRI of formula (I). This innovation is crucial for advancing treatment options for patients facing multidrug resistance.

Career Highlights

Catherine has been associated with Glaxo Wellcome Inc., where she has contributed her expertise in pharmaceutical research and development. Her work has been instrumental in creating effective solutions for complex medical challenges. With her dedication and innovative spirit, she continues to push the boundaries of what is possible in her field.

Collaborations

Catherine has collaborated with talented individuals such as Matthew J Sharp and Calum Strachan. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Catherine J Mader's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her importance as an inventor. Her work not only addresses critical health issues but also inspires future advancements in medical research.